(CROX) Crocs - Ratings and Ratios
Clogs,Sandals,Sneakers,Slides,Charms
CROX EPS (Earnings per Share)
CROX Revenue
Description: CROX Crocs
Crocs Inc (NASDAQ:CROX) is a leading global footwear brand that designs, manufactures, and distributes casual lifestyle footwear and accessories under the Crocs and HEYDUDE brands. The companys product portfolio includes a wide range of footwear styles, such as clogs, sandals, and sneakers, as well as accessories like straps, bags, and charms. With a strong presence in the US and international markets, Crocs sells its products through various channels, including wholesalers, retail stores, e-commerce sites, and third-party marketplaces.
From a financial perspective, Crocs has demonstrated strong performance in recent years, driven by its ability to innovate and expand its product offerings. Key performance indicators (KPIs) such as revenue growth, gross margin, and operating margin are crucial in evaluating the companys financial health. Notably, Crocs has achieved significant revenue growth, with a compound annual growth rate (CAGR) of over 10% in recent years. Additionally, the companys gross margin has remained stable, indicating effective cost management and pricing strategies.
To further analyze Crocs performance, other relevant KPIs include same-store sales growth, e-commerce sales growth, and brand awareness metrics. The companys ability to drive sales growth through its e-commerce platform and expand its brand presence globally are critical factors in its long-term success. Furthermore, metrics such as inventory turnover, accounts receivable turnover, and days sales outstanding (DSO) provide insights into the companys operational efficiency and working capital management.
With a market capitalization of approximately $5.8 billion and a forward P/E ratio of 8.87, Crocs valuation appears reasonable compared to its peers in the footwear industry. The companys strong return on equity (ROE) of 53.33% indicates effective use of shareholder capital and a robust business model. As a Trading Analyst, it is essential to continue monitoring Crocs financial performance, industry trends, and competitive landscape to identify potential investment opportunities.
CROX Stock Overview
| Market Cap in USD | 4,433m |
| Sub-Industry | Footwear |
| IPO / Inception | 2006-02-08 |
CROX Stock Ratings
| Growth Rating | -22.8% |
| Fundamental | 72.1% |
| Dividend Rating | - |
| Return 12m vs S&P 500 | -51.8% |
| Analyst Rating | 4.20 of 5 |
CROX Dividends
Currently no dividends paidCROX Growth Ratios
| Growth Correlation 3m | -66.9% |
| Growth Correlation 12m | -63.3% |
| Growth Correlation 5y | 30.3% |
| CAGR 5y | -0.36% |
| CAGR/Max DD 3y | -0.01 |
| CAGR/Mean DD 3y | -0.01 |
| Sharpe Ratio 12m | -1.65 |
| Alpha | -50.53 |
| Beta | 0.417 |
| Volatility | 52.16% |
| Current Volume | 2359.5k |
| Average Volume 20d | 1824.7k |
| Stop Loss | 74 (-4.6%) |
| Signal | 0.21 |
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income (236.5m TTM) > 0 and > 6% of Revenue (6% = 248.3m TTM) |
| FCFTA 0.17 (>2.0%) and ΔFCFTA -1.30pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 9.35% (prev 8.39%; Δ 0.96pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.19 (>3.0%) and CFO 837.4m > Net Income 236.5m (YES >=105%, WARN >=100%) |
| Net Debt (1.57b) to EBITDA (345.4m) ratio: 4.55 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.54 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (55.9m) change vs 12m ago -7.93% (target <= -2.0% for YES) |
| Gross Margin 59.36% (prev 57.11%; Δ 2.25pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 90.26% (prev 85.93%; Δ 4.33pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 2.86 (EBITDA TTM 345.4m / Interest Expense TTM 94.8m) >= 6 (WARN >= 3) |
Altman Z'' 4.44
| (A) 0.09 = (Total Current Assets 1.10b - Total Current Liabilities 714.8m) / Total Assets 4.45b |
| (B) 0.73 = Retained Earnings (Balance) 3.23b / Total Assets 4.45b |
| (C) 0.06 = EBIT TTM 271.3m / Avg Total Assets 4.59b |
| (D) 1.05 = Book Value of Equity 3.19b / Total Liabilities 3.03b |
| Total Rating: 4.44 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 72.13
| 1. Piotroski 5.0pt = 0.0 |
| 2. FCF Yield 13.31% = 5.0 |
| 3. FCF Margin 18.58% = 4.64 |
| 4. Debt/Equity 1.09 = 1.94 |
| 5. Debt/Ebitda 4.47 = -2.50 |
| 6. ROIC - WACC 8.10% = 10.13 |
| 7. RoE 13.61% = 1.13 |
| 8. Rev. Trend 40.06% = 2.00 |
| 9. Rev. CAGR 5.77% = 0.72 |
| 10. EPS Trend -37.52% = -0.94 |
| 11. EPS CAGR 0.0% = 0.0 |
What is the price of CROX shares?
Over the past week, the price has changed by -11.02%, over one month by -8.41%, over three months by -24.12% and over the past year by -42.73%.
Is Crocs a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CROX is around 59.87 USD . This means that CROX is currently overvalued and has a potential downside of -22.83%.
Is CROX a buy, sell or hold?
- Strong Buy: 7
- Buy: 4
- Hold: 4
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the CROX price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 91.8 | 18.4% |
| Analysts Target Price | 91.8 | 18.4% |
| ValueRay Target Price | 66.2 | -14.7% |
Last update: 2025-09-12 04:34
CROX Fundamental Data Overview
CCE Cash And Equivalents = 200.6m USD (Cash And Short Term Investments, last quarter)
P/E Trailing = 22.0571
P/E Forward = 8.9206
P/S = 1.0712
P/B = 3.1195
P/EG = -31.83
Beta = 1.397
Revenue TTM = 4.14b USD
EBIT TTM = 271.3m USD
EBITDA TTM = 345.4m USD
Long Term Debt = 1.38b USD (from longTermDebt, last quarter)
Short Term Debt = 165.8m USD (from shortTermDebt, last quarter)
Debt = 1.54b USD (Calculated: Short Term 165.8m + Long Term 1.38b)
Net Debt = 1.57b USD (from netDebt column, last quarter)
Enterprise Value = 5.78b USD (4.43b + Debt 1.54b - CCE 200.6m)
Interest Coverage Ratio = 2.86 (Ebit TTM 271.3m / Interest Expense TTM 94.8m)
FCF Yield = 13.31% (FCF TTM 768.9m / Enterprise Value 5.78b)
FCF Margin = 18.58% (FCF TTM 768.9m / Revenue TTM 4.14b)
Net Margin = 5.72% (Net Income TTM 236.5m / Revenue TTM 4.14b)
Gross Margin = 59.36% ((Revenue TTM 4.14b - Cost of Revenue TTM 1.68b) / Revenue TTM)
Tobins Q-Ratio = 1.81 (Enterprise Value 5.78b / Book Value Of Equity 3.19b)
Interest Expense / Debt = 1.46% (Interest Expense 22.5m / Debt 1.54b)
Taxrate = -4.34% (set to none) (-39.5m / 910.6m)
NOPAT = unknown (EBIT/Op.Income or Taxrate missing)
Current Ratio = 1.54 (Total Current Assets 1.10b / Total Current Liabilities 714.8m)
Debt / Equity = 1.09 (Debt 1.54b / last Quarter total Stockholder Equity 1.42b)
Debt / EBITDA = 4.47 (Net Debt 1.57b / EBITDA 345.4m)
Debt / FCF = 2.01 (Debt 1.54b / FCF TTM 768.9m)
Total Stockholder Equity = 1.74b (last 4 quarters mean)
RoA = 5.31% (Net Income 236.5m, Total Assets 4.45b )
RoE = 13.61% (Net Income TTM 236.5m / Total Stockholder Equity 1.74b)
RoCE = 8.70% (Ebit 271.3m / (Equity 1.74b + L.T.Debt 1.38b))
RoIC = 8.10% (Ebit 271.3m / (Assets 4.45b - Current Assets 1.10b))
WACC = unknown (E(4.43b)/V(5.98b) * Re(7.55%)) + (D(1.54b)/V(5.98b) * Rd(1.46%) * (1-Tc(none)))
Shares Correlation 3-Years: -81.82 | Cagr: -0.98%
Discount Rate = 7.55% (= CAPM, Blume Beta Adj.) -> floored to rf + ERP 8.05%
[DCF Debug] Terminal Value 79.96% ; FCFE base≈812.0m ; Y1≈917.5m ; Y5≈1.24b
Fair Price DCF = 394.0 (DCF Value 21.52b / Shares Outstanding 54.6m; 5y FCF grow 15.10% → 3.0% )
Revenue Correlation: 40.06 | Revenue CAGR: 5.77%
Rev Growth-of-Growth: -1.79
EPS Correlation: -37.52 | EPS CAGR: 0.0%
EPS Growth-of-Growth: -74.60
Additional Sources for CROX Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle